Thromb Haemost 1961; 6(01): 160-171
DOI: 10.1055/s-0038-1654549
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Bridge Anticoagulant, a New Entity?

E Mulder M.D.
1   Paediatric Clinic of the University of Amsterdam (Head: Prof. Dr. S. van Creveld)
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

Preview

Summary

After a critical analysis of the work of Nour Eldin and Wilkinson on the so-called Bridge anticoagulant, the author presents his own experimental work on this subject. It is concluded that one part of the evidence for a new inhibitor is not reproduceable, and that the other part depends on the presence of an inhibitor, anticephalin. This inhibitor has been known to exist for many years.